Lilly Seeks Emergency Authorization for Covid Antibody Drug

(Bloomberg) -- Eli Lilly & Co. asked U.S. drug regulators to authorize emergency use of its experimental Covid-19 antibody therapy after data showed the treatment reduced hospitalizations.